Utrecht Holdings appeared to be the Corporate Investor, which was created in 1998.
The fund has no exact preference in a number of founders of portfolio startups. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Gadeta, Mucosis. Among the most popular fund investment industries, there are Medical, Therapeutics.
The fund is constantly included in less than 2 investment rounds annually. The common things for fund are deals in the range of 5 - 10 millions dollars. The top activity for fund was in 2016.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Utrecht Holdings, startups are often financed by Thuja Capital, NV NOM, MedSciences Capital. The meaningful sponsors for the fund in investment in the same round are Thuja Capital, NV NOM, Medicxi Ventures. In the next rounds fund is usually obtained by Wellcome Trust, Kite Pharma, BioGeneration Ventures.
Related Funds
| Fund Name | Location |
| BankInvest | Copenhagen, Denmark, Hovedstaden |
| BRC Investments | Connecticut, United States, Westport |
| Canadian Government | Canada, Ontario, Ottawa |
| Cheers Capital Partners | China, Hongkou District |
| Clayton Associates | Nashville, Tennessee, United States |
| Clemons Management | - |
| FaciliTO | - |
| Financial Venture Studio | California, San Francisco, United States |
| Gaia Enterprise | - |
| Global Asset Fund | Bayern, Germany, Landshut |
| Gortune Investment | China, Guangdong, Guangzhou |
| Huoerguosi Dao Yang Chuangye Touzi | China, Ilin, Jiangsu |
| Kaixin Investment | Beijing, Beijing, China |
| Magellan Bioscience Group | Florida, Tampa, United States |
| MedioStream | California, Los Altos, United States |
| Point Break Capital | - |
| True Northland | - |
| Youngor Group | China, Ningbo, Zhejiang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Synerkine Pharma | $4M | 16 Dec 2021 | Utrecht, Utrecht, Netherlands | ||
Gadeta | $8M | 29 Mar 2016 | Utrecht | ||
Cavadis | 26 May 2009 | Utrecht, Utrecht, Netherlands |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Synerkine Pharma | $4M | 16 Dec 2021 | Utrecht, Utrecht, Netherlands | ||
Gadeta | $8M | 29 Mar 2016 | Utrecht | ||
Cavadis | 26 May 2009 | Utrecht, Utrecht, Netherlands |
